Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Proponents often stress the possibility for significant therapeutic outcomes, particularly in conditions where conventional treatments have proven limited. However, crucially important to evaluate the considerable financial burden associated with CPI ste